Cite Filings / SPRY / 9999999995-23-001273

Feed Companies Filings Check

Sign in

EFFECT

Notice of Effectiveness

ARS Pharmaceuticals, Inc. Filed 2023-05-03 Acc 9999999995-23-001273

Documents 1

EFFECT Notice of Effectiveness , xslEFFECTX01/primary_doc.xml

Around this filing

2023-05-08 144 Sale of Securities
2023-05-03 EFFECT Notice of Effectiveness
2023-05-01 CORRESP Correspondence Between Filers and SEC Staff
2023-05-01 ARS Annual Report to Security Holders
2023-05-01 DEFA14A Proxy Materials
2023-05-01 DEF 14A Proxy Statement
2022-01-13 EFFECT Notice of Effectiveness

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…